name: | Troriluzole |
ATC code: | N07XX23 | route: | oral |
n-compartments | 1 |
Troriluzole is a prodrug of riluzole, an investigational agent designed to modulate glutamatergic neurotransmission. It is under development primarily for neurological and neuropsychiatric disorders including Alzheimer's disease, spinocerebellar ataxia, and obsessive-compulsive disorder. Troriluzole is not currently approved for medical use.
Estimated pharmacokinetic parameters for oral administration in healthy adults based on prodrug characteristics and limited clinical summary data available from secondary sources.